| Public | NYSE:BSX |
| Raised | |
| Post IPO Valuation |
| Website | bostonscientific.com |
| Phone | 508-650-8000 |
| Employees |
| Total | $897M |
| Rhythmia Medical, 10/12 | |
| BridgePoint Medical, 9/12 | |
| Atritech, 1/11 | $375M |
| Intelect Medical, 1/11 | $78M |
| Sadra Medical, 11/10 | |
| Asthmatx, 9/10 | $444M |
| Endotex, 1/07 |
| Channel Medsystems | 5/13 |
Boston Scientific has advanced the practice of less-invasive medicine by providing a broad and deep portfolio of innovative products, technologies and services across a wide range of medical specialties. These less-invasive medical technologies provide alternatives to major surgery and other medical procedures that are typically traumatic to the body. In less-invasive procedures, devices are usually inserted into the body through natural openings or small incisions and can be guided to most areas of the anatomy to diagnose and treat a wide range of medical problems.